Terray Therapeutics

About:

Terray Therapeutics is a biotechnology company that propels drug discovery into the information age.

Website: https://terraytx.com

Twitter/X: terray_tx

Top Investors: NVentures, Alexandria Venture Investments, Madrona, Two Sigma Ventures, Goldcrest Capital

Description:

Terray Therapeutics is a biotechnology company that propels drug discovery into the information age. It is led by leaders in artificial intelligence, synthetic (medicinal) chemistry, biology, preclinical development, automation, and nanotechnology. Chemical datasets generated with its novel ultra-dense microarray technology integrate seamlessly with its integrated machine learning and computational platform to map biochemical interactions between small molecules and disease causes. AI and machine learning models are powered by iterative cycles of virtual molecular design and experimentation, which in turn guide the next design cycle. The company was founded in 2018 and is based in Pasadena, California.

Total Funding Amount:

$80M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Pasadena, California, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)terraytx.com

Founders:

Eli Berlin

Number of Employees:

51-100

Last Funding Date:

2023-11-09

IPO Status:

Private

© 2024 MyAiNote.com